List of Tables
Table 1. Global Sunitinib Generics Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Sunitinib Generics Market Value by Application (2024-2030) & (US$ Million)
Table 3. Global Sunitinib Generics Market Competitive Situation by Manufacturers in 2023
Table 4. Global Sunitinib Generics Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Sunitinib Generics Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Sunitinib Generics Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Sunitinib Generics Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Sunitinib Generics Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Sunitinib Generics, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Sunitinib Generics, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Sunitinib Generics, Product Type & Application
Table 12. Global Key Manufacturers of Sunitinib Generics, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Sunitinib Generics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sunitinib Generics as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Sunitinib Generics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Sunitinib Generics Sales by Region (2019-2024) & (K Units)
Table 18. Global Sunitinib Generics Sales Market Share by Region (2019-2024)
Table 19. Global Sunitinib Generics Sales by Region (2025-2030) & (K Units)
Table 20. Global Sunitinib Generics Sales Market Share by Region (2025-2030)
Table 21. Global Sunitinib Generics Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Sunitinib Generics Revenue Market Share by Region (2019-2024)
Table 23. Global Sunitinib Generics Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Sunitinib Generics Revenue Market Share by Region (2025-2030)
Table 25. North America Sunitinib Generics Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Sunitinib Generics Sales by Country (2019-2024) & (K Units)
Table 27. North America Sunitinib Generics Sales by Country (2025-2030) & (K Units)
Table 28. North America Sunitinib Generics Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Sunitinib Generics Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Sunitinib Generics Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Sunitinib Generics Sales by Country (2019-2024) & (K Units)
Table 32. Europe Sunitinib Generics Sales by Country (2025-2030) & (K Units)
Table 33. Europe Sunitinib Generics Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Sunitinib Generics Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Sunitinib Generics Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Sunitinib Generics Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Sunitinib Generics Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Sunitinib Generics Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Sunitinib Generics Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Sunitinib Generics Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Sunitinib Generics Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Sunitinib Generics Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Sunitinib Generics Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Sunitinib Generics Revenue Market Share by Country (2019-2024)
Table 45. Middle East and Africa Sunitinib Generics Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East and Africa Sunitinib Generics Sales by Country (2019-2024) & (K Units)
Table 47. Middle East and Africa Sunitinib Generics Sales by Country (2025-2030) & (K Units)
Table 48. Middle East and Africa Sunitinib Generics Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East and Africa Sunitinib Generics Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Sunitinib Generics Sales (K Units) by Type (2019-2024)
Table 51. Global Sunitinib Generics Sales (K Units) by Type (2025-2030)
Table 52. Global Sunitinib Generics Sales Market Share by Type (2019-2024)
Table 53. Global Sunitinib Generics Sales Market Share by Type (2025-2030)
Table 54. Global Sunitinib Generics Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Sunitinib Generics Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Sunitinib Generics Revenue Market Share by Type (2019-2024)
Table 57. Global Sunitinib Generics Revenue Market Share by Type (2025-2030)
Table 58. Global Sunitinib Generics Price (US$/Unit) by Type (2019-2024)
Table 59. Global Sunitinib Generics Price (US$/Unit) by Type (2025-2030)
Table 60. Global Sunitinib Generics Sales (K Units) by Application (2019-2024)
Table 61. Global Sunitinib Generics Sales (K Units) by Application (2025-2030)
Table 62. Global Sunitinib Generics Sales Market Share by Application (2019-2024)
Table 63. Global Sunitinib Generics Sales Market Share by Application (2025-2030)
Table 64. Global Sunitinib Generics Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Sunitinib Generics Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Sunitinib Generics Revenue Market Share by Application (2019-2024)
Table 67. Global Sunitinib Generics Revenue Market Share by Application (2025-2030)
Table 68. Global Sunitinib Generics Price (US$/Unit) by Application (2019-2024)
Table 69. Global Sunitinib Generics Price (US$/Unit) by Application (2025-2030)
Table 70. Teva Company Information
Table 71. Teva Description and Business Overview
Table 72. Teva Sunitinib Generics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Teva Sunitinib Generics Product
Table 74. Teva Recent Developments/Updates
Table 75. Zydus Company Information
Table 76. Zydus Description and Business Overview
Table 77. Zydus Sunitinib Generics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Zydus Sunitinib Generics Product
Table 79. Zydus Recent Developments/Updates
Table 80. Aprazer Healthcare Company Information
Table 81. Aprazer Healthcare Description and Business Overview
Table 82. Aprazer Healthcare Sunitinib Generics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Aprazer Healthcare Sunitinib Generics Product
Table 84. Aprazer Healthcare Recent Developments/Updates
Table 85. Taj Pharma Company Information
Table 86. Taj Pharma Description and Business Overview
Table 87. Taj Pharma Sunitinib Generics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Taj Pharma Sunitinib Generics Product
Table 89. Taj Pharma Recent Developments/Updates
Table 90. Qilu Pharmaceutical Company Information
Table 91. Qilu Pharmaceutical Description and Business Overview
Table 92. Qilu Pharmaceutical Sunitinib Generics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Qilu Pharmaceutical Sunitinib Generics Product
Table 94. Qilu Pharmaceutical Recent Developments/Updates
Table 95. CSPC Pharmaceutical Company Information
Table 96. CSPC Pharmaceutical Description and Business Overview
Table 97. CSPC Pharmaceutical Sunitinib Generics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. CSPC Pharmaceutical Sunitinib Generics Product
Table 99. CSPC Pharmaceutical Recent Developments/Updates
Table 100. Hansoh Pharma Company Information
Table 101. Hansoh Pharma Description and Business Overview
Table 102. Hansoh Pharma Sunitinib Generics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Hansoh Pharma Sunitinib Generics Product
Table 104. Hansoh Pharma Recent Developments/Updates
Table 105. Chia Tai Tianqing Company Information
Table 106. Chia Tai Tianqing Description and Business Overview
Table 107. Chia Tai Tianqing Sunitinib Generics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Chia Tai Tianqing Sunitinib Generics Product
Table 109. Chia Tai Tianqing Recent Developments/Updates
Table 110. Hunan Kelun Pharmaceutical Company Information
Table 111. Hunan Kelun Pharmaceutical Description and Business Overview
Table 112. Hunan Kelun Pharmaceutical Sunitinib Generics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Hunan Kelun Pharmaceutical Sunitinib Generics Product
Table 114. Hunan Kelun Pharmaceutical Recent Developments/Updates
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. Sunitinib Generics Distributors List
Table 118. Sunitinib Generics Customers List
Table 119. Sunitinib Generics Market Trends
Table 120. Sunitinib Generics Market Drivers
Table 121. Sunitinib Generics Market Challenges
Table 122. Sunitinib Generics Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
Table 126. Authors List of This Report
List of Figures
Figure 1. Product Picture of Sunitinib Generics
Figure 2. Global Sunitinib Generics Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Sunitinib Generics Market Share by Type: 2023 & 2030
Figure 4. 12.5mg per Unit Product Picture
Figure 5. 20mg per Unit Product Picture
Figure 6. 37.5mg per Unit Product Picture
Figure 7. 50mg per Unit Product Picture
Figure 8. Global Sunitinib Generics Market Value by Application (2024-2030) & (US$ Million)
Figure 9. Global Sunitinib Generics Market Share by Application: 2023 & 2030
Figure 10. Renal cell Carcinoma
Figure 11. Gastrointestinal Stromal Tumors
Figure 12. Pancreatic Neuroendocrine Tumors
Figure 13. Other
Figure 14. Global Sunitinib Generics Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Sunitinib Generics Market Size (2019-2030) & (US$ Million)
Figure 16. Global Sunitinib Generics Sales (2019-2030) & (K Units)
Figure 17. Global Sunitinib Generics Average Price (US$/Unit) & (2019-2030)
Figure 18. Sunitinib Generics Report Years Considered
Figure 19. Sunitinib Generics Sales Share by Manufacturers in 2023
Figure 20. Global Sunitinib Generics Revenue Share by Manufacturers in 2023
Figure 21. Global 5 and 10 Largest Sunitinib Generics Players: Market Share by Revenue in Sunitinib Generics in 2023
Figure 22. Sunitinib Generics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 23. Global Sunitinib Generics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 24. North America Sunitinib Generics Sales Market Share by Country (2019-2030)
Figure 25. North America Sunitinib Generics Revenue Market Share by Country (2019-2030)
Figure 26. United States Sunitinib Generics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. Canada Sunitinib Generics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. Europe Sunitinib Generics Sales Market Share by Country (2019-2030)
Figure 29. Europe Sunitinib Generics Revenue Market Share by Country (2019-2030)
Figure 30. Germany Sunitinib Generics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. France Sunitinib Generics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. U.K. Sunitinib Generics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Italy Sunitinib Generics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Russia Sunitinib Generics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Asia Pacific Sunitinib Generics Sales Market Share by Region (2019-2030)
Figure 36. Asia Pacific Sunitinib Generics Revenue Market Share by Region (2019-2030)
Figure 37. China Sunitinib Generics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Japan Sunitinib Generics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. South Korea Sunitinib Generics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. India Sunitinib Generics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Australia Sunitinib Generics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. China Taiwan Sunitinib Generics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Southeast Asia Sunitinib Generics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Latin America Sunitinib Generics Sales Market Share by Country (2019-2030)
Figure 45. Mexico Sunitinib Generics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Brazil Sunitinib Generics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Argentina Sunitinib Generics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Colombia Sunitinib Generics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Middle East and Africa Sunitinib Generics Sales Market Share by Country (2019-2030)
Figure 50. Middle East and Africa Sunitinib Generics Revenue Market Share by Country (2019-2030)
Figure 51. Turkey Sunitinib Generics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Saudi Arabia Sunitinib Generics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. UAE Sunitinib Generics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Global Sales Market Share of Sunitinib Generics by Type (2019-2030)
Figure 55. Global Revenue Market Share of Sunitinib Generics by Type (2019-2030)
Figure 56. Global Sunitinib Generics Price (US$/Unit) by Type (2019-2030)
Figure 57. Global Sales Market Share of Sunitinib Generics by Application (2019-2030)
Figure 58. Global Revenue Market Share of Sunitinib Generics by Application (2019-2030)
Figure 59. Global Sunitinib Generics Price (US$/Unit) by Application (2019-2030)
Figure 60. Sunitinib Generics Value Chain
Figure 61. Sunitinib Generics Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
